Off-Label / InvestigationalEmerging EvidenceNeurological
Alzheimer's Disease & Cognitive Decline
HBOT is investigated for its ability to improve cerebral blood flow, reduce neuroinflammation, enhance amyloid clearance, and support neuroplasticity in Alzheimer's patients.
Typical Protocol at a Glance
Pressure
2 ATA
Duration
90 min
Sessions
60
Medical Disclaimer
This information is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting HBOT or any treatment. Individual results may vary.